We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-5.64%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$741B
AUM Growth
-$68.4B
Cap. Flow
-$3.25B
Cap. Flow %
-0.44%
Top 10 Hldgs %
15.48%
Holding
8,434
New
238
Increased
3,520
Reduced
3,560
Closed
255

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$2.61B
2
EPAM icon
EPAM Systems
EPAM
+$1.48B
3
TWLO icon
Twilio
TWLO
+$1.35B
4
AAPL icon
Apple
AAPL
+$1.24B
5
TWTR
Twitter, Inc.
TWTR
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Healthcare 9.76%
3 Financials 9.11%
4 Consumer Discretionary 8.41%
5 Communication Services 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBPS
5701
DELISTED
4D Pharma PLC
LBPS
$210K ﹤0.01%
43,363
+22,594
+109% +$94.4K
ESML icon
5702
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.96B
$209K ﹤0.01%
5,494
-18,126
-77% -$683K
MXF
5703
Mexico Fund
MXF
$309M
$209K ﹤0.01%
12,614
-1,905
-13% -$29.3K
SOS
5704
SOS Limited
SOS
$16.7M
$209K ﹤0.01%
517
-11,590
-96% -$6.32M
CRTD
5705
DELISTED
Creatd Inc. Common Stock
CRTD
$209K ﹤0.01%
+182,132
New +$286K
ABSI icon
5706
Absci
ABSI
$1.63B
$208K ﹤0.01%
24,610
+7,314
+42% +$57.5K
HRTG icon
5707
Heritage Insurance Holdings
HRTG
$989M
$208K ﹤0.01%
29,139
-52,532
-64% -$325K
VWE
5708
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$208K ﹤0.01%
20,969
+13,074
+166% +$117K
BTWN
5709
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$208K ﹤0.01%
21,107
-98,492
-82% -$968K
BUR icon
5710
Burford Capital
BUR
$962M
$207K ﹤0.01%
22,519
+13,692
+155% +$130K
CMCL icon
5711
Caledonia Mining Corp
CMCL
$439M
$207K ﹤0.01%
13,600
-552
-4% -$6.96K
DSGN icon
5712
Design Therapeutics
DSGN
$901M
$207K ﹤0.01%
12,816
-488
-4% -$7.47K
MRNS
5713
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$207K ﹤0.01%
22,041
-16,117
-42% -$160K
FRLN
5714
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$207K ﹤0.01%
12,315
+5,213
+73% +$96.7K
BCTX
5715
Briacell Therapeutics
BCTX
$29.7M
$206K ﹤0.01%
135
+80
+145% +$94.7K
CTMX icon
5716
CytomX Therapeutics
CTMX
$730M
$206K ﹤0.01%
77,654
-9,589
-11% -$36.8K
SALM
5717
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$206K ﹤0.01%
60,817
+21,809
+56% +$74.7K
EQOS
5718
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$206K ﹤0.01%
92,228
+1,980
+2% +$3.76K
ZOM
5719
DELISTED
Zomedica Corp.
ZOM
$206K ﹤0.01%
611,965
-20,550
-3% -$6.72K
TRIN icon
5720
Trinity Capital Inc.
TRIN
$1.75B
$205K ﹤0.01%
10,596
+7,086
+202% +$127K
GSIT icon
5721
GSI Technology
GSIT
$260M
$204K ﹤0.01%
53,241
+2,960
+6% +$12.7K
AKO.B icon
5722
Embotelladora Andina Series B
AKO.B
$4.89B
$203K ﹤0.01%
14,932
-73
-0.5% -$931
CABA icon
5723
Cabaletta Bio
CABA
$465M
$203K ﹤0.01%
99,897
+49,326
+98% +$129K
SPIR icon
5724
Spire Global
SPIR
$540M
$203K ﹤0.01%
12,126
-18,086
-60% -$353K
NAGE
5725
Niagen Bioscience
NAGE
$241M
$203K ﹤0.01%
82,681
-2,655
-3% -$7.25K

Similar funds

Morgan Stanley's Q1 2022 Portfolio in Review

As of Q1 2022, Morgan Stanley held 8,434 positions worth $741B, down 8.4% from $810B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q1 2022 filing shows 238 new, 3,520 increased, 3,560 reduced and 255 closed positions. Its largest new stake was Shell: 4,762,346 shares worth $262M. The largest sale was Mastercard, an estimated $2.61B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q1 2022 buy was Shell: 4,762,346 shares worth $262M.
  • Morgan Stanley added most to iShares 20+ Year Treasury Bond ETF in Q1 2022, an estimated $1.86B increase.
  • Morgan Stanley's biggest Q1 2022 reduction was Mastercard, cutting an estimated $2.61B.
  • Morgan Stanley fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $961M.
  • Morgan Stanley's ten largest holdings make up 15% of its $741B portfolio in Q1 2022.
  • Morgan Stanley opened 238 new positions and closed 255 in Q1 2022.
  • Morgan Stanley's portfolio value fell 8.4% quarter-over-quarter to $741B.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.